Vimarsana
Biggest News Aggregation in the World

Page 2 - Vida Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vida Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vida Ventures Today - Breaking & Trending Today

Biotech Kyverna Therapeutics Tops IPO Goal to Raise $319 Million - Vimarsana News

Biotech Kyverna Therapeutics Tops IPO Goal to Raise $319 Million

(Bloomberg) -- Kyverna Therapeutics Inc. raised $319 million in a US initial public offering priced above a marketed range, as drug developers continue to receive a warm welcome from new investors.Most Read from BloombergCitadel Among Hedge Funds That Got Morgan Stanley’s Block-Trading LeaksTesla Asks Which Jobs Are Critical, Stoking Layoff FearsChina Replaces Top Markets Regulator as Xi Tries to End RoutUS Commercial Real Estate Contagion Is Now Moving to EuropeHaley Loses Nevada Primary to ‘No

Source: yahoo.com
Exclusive: What Andreessen Horowitz's Anish Acharya is looking for in consumer AI startups - Vimarsana News

Exclusive: What Andreessen Horowitz's Anish Acharya is looking for in consumer AI startups

A16z’s consumer AI bets will emphasize creative applications, improved workflows, and AI companionship.

AVROBIO and Tectonic Therapeutic Announce Merger - Vimarsana News

AVROBIO and Tectonic Therapeutic Announce Merger

Combined company to be Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Tectonic’s novel GPCR-targeted therapeutic proteins $130.7 million in private financing...

At Davos, Sam Altman is a headliner, with star status scrutiny to match - Vimarsana News

At Davos, Sam Altman is a headliner, with star status scrutiny to match

Sam Altman is a leading voice at Davos, which means he’s sounding off on everything from elections to energy. It also means he’s more watched than ever.

Volastra Therapeutics Appoints David Nicholson, Ph.D., to Board of Directors - Vimarsana News

Volastra Therapeutics Appoints David Nicholson, Ph.D., to Board of Directors

Life sciences veteran’s experience leading R&D organizations and bringing more than 25 products to market will support Volastra’s growing pipeline of treatments targeting chromosomally unstable cancersNEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a clinical-stage cancer biotechnology company, today announced the...